Argentum is a generic drug company with core competencies in intellectual property and pharmaceutical operations. By working with branded and generic pharmaceutical companies and healthcare payors we intend to reduce the overall cost of prescription drugs by challenging patents that are not innovative and which artificially support high drug prices.
Useful commentary, tools and resources for learning more about FDA approved pharmaceuticals, patents, and the Inter Partes Review process.
Argentum is dedicated to supporting innovative and cost effective treatment options for patients, by acquiring, developing and marketing new generic drugs. Argentum welcomes partnering opportunities that support or complement our business strategies.